...
首页> 外文期刊>Clinical rheumatology >Comparison of hyaluronic acid and PRP intra-articular injection with combined intra-articular and intraosseous PRP injections to treat patients with knee osteoarthritis
【24h】

Comparison of hyaluronic acid and PRP intra-articular injection with combined intra-articular and intraosseous PRP injections to treat patients with knee osteoarthritis

机译:透明质酸和PRP内注射症的比较与关节内和骨内PRP注射组合治疗膝关节骨关节炎患者

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to evaluate the benefit provided by intraosseous infiltration combined with intra-articular injection of platelet-rich plasma to treat mild and moderate stages of knee joint degeneration (Kellgren-Lawrence score II-III) compared with other treatments, specifically intra-articular injection of PRP and of HA. Eighty-six patients with grade II to grade III knee OA according to the Kellgren-Lawrence classification were randomly assigned to intra-articular combined with intraosseous injection of PRP (group A), intra-articular PRP (group B), or intra-articular HA (group C). Patients in group A received intra-articular combined with intraosseous injection of PRP (administered twice, 2 weeks apart). Patients in group B received intra-articular injection of PRP every 14 days. Patients in group C received a series of five intra-articular injections of HA every 7 days. All patients were evaluated using the Visual Analogue Scale (VAS) and Western Ontario and McMaster Universities (WOMAC) score before the treatment and at 1, 3, 6, 12, and 18 months after treatment. There were significant improvements at the end of the 1st month. Notably, group A patients had significantly superior VAS and WOMAC scores than were observed in groups B and C. The VAS scores were similar in groups B and group C after the 6th month. Regarding the WOMAC scores, groups B and C differed at the 1st, 3rd, 6th, and 12th months; however, no significant difference was observed at the 18th month. The combination of intraosseous with intra-articular injections of PRP resulted in a significantly superior clinical outcome, with sustained lower VAS and WOMAC scores and improvement in quality of life within 18 months.
机译:本研究的目的是评估骨内浸润所提供的损害,所述渗透性与特性富含血小板的血浆的血糖注射,以治疗与其他治疗相比的膝关节退化(Kellgren-Lawrence得分III-III)的温和和中等阶段。关节内注射PRP和HA。根据Kellgren-Lawrence分类的II级等级II级九级患者随机分配给关节内注射PRP(a),关节内PRP(B组)或关节内的骨内注射哈(C组)。 A组患者接受关节内的结合与骨髓内注射PRP(分别施用两次)。 B组患者每14天接受关节内注射PRP。 C组患者每7天收到一系列五种关节内注射HA。所有患者均使用视觉模拟量表(VAS)和麦克马斯特大学(WOWAC)分数在治疗前,治疗后1,3,6,12和18个月评估。第1个月底存在重大改善。值得注意的是,组患者的VAS和WOMAC分数显着优于B和C组和C. VAS分数在第6个月后B组和C组。关于WOMAC分数,B组和C群体在第1,第3号,第6个和第12个月内不同;但是,在第18个月内没有观察到显着差异。骨内注射治疗PRP的组合导致了显着优异的临床结果,持续较低的VAS和WOMAC分数,18个月内的生活质量提高。

著录项

  • 来源
    《Clinical rheumatology》 |2018年第5期|共10页
  • 作者单位

    Cangzhou Cent Hosp Dept Orthopaed Surg Arthroscop Surg Unit Cangzhou Shi 061001 Hebei Peoples;

    Cangzhou Cent Hosp Dept Orthopaed Surg Arthroscop Surg Unit Cangzhou Shi 061001 Hebei Peoples;

    Cangzhou Cent Hosp Dept Orthopaed Surg Arthroscop Surg Unit Cangzhou Shi 061001 Hebei Peoples;

    Cangzhou Cent Hosp Dept Orthopaed Surg Arthroscop Surg Unit Cangzhou Shi 061001 Hebei Peoples;

    Cangzhou Cent Hosp Dept Lab Blood Test Unit Cangzhou Shi Hebei Peoples R China;

    Cangzhou Cent Hosp Dept Orthopaed Surg Arthroscop Surg Unit Cangzhou Shi 061001 Hebei Peoples;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内科学;
  • 关键词

    Hyaluronic acid; Intra-articular injection; Knee osteoarthritis; Platelet-rich plasma;

    机译:透明质酸;关节内注射;膝关节骨关节炎;富含血小板的血浆;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号